Mirza Mohd Kamran

Dr. Mirza Mohd Kamran


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2023 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
MKMirza Mohd Kamran
Mirza Mohd Kamran
AGArun Gopi
Arun Gopi
ZLZeeshan Lakhani
Zeeshan Lakhani
ASAmira Shaik
Amira Shaik
JMJaneel Musthafa
Janeel Musthafa
PMP. P. Mohammed Musthafa
P. P. Mohammed Musthafa

2 May 2022 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
MKMirza Mohd Kamran
Mirza Mohd Kamran
SAShaad Abqari
Shaad Abqari
AHAzam Haseen
Azam Haseen
MYMayank Yadav
Mayank Yadav
Introduction: Ventricular septal defect is one of the commonest heart defect in children and closure of this defect with devices has seen a rapid progression over a period of time. The availability of new and safer devices has made the transcatheter closure of ventricular septal defect a suitable option even in young children.Aim: The study was done to evaluate the feasibility and complications of device closure of ventricular septal defect in children weighing 10 kg or less with different types of devices.Methods: The present study was undertaken in a newly established dedicated Paediatric Cardiac Unit at a Tertiary Care Hospital. Relevant data were obtained retrospectively from the case files and the catheterisation records and data were analysed for first 50 patients with ventricular septal defect weighing 10 kg or less between March 2018 and March 2021.Results: Among these 50 patients selected, device closure was successfully done in 45 (90%) cases while 5 (10%) attempts were unsuccessful for various reasons. The mean weight in this study was 7.46 ± 1.89 kg (2.3–10 kg), 21 (42%) cases were females while 29 (58%) were males; mean age was 19.4 ± 11.88 months (4–48 months). Right heart catheterisation study showed 21 (42%) patients with normal pulmonary artery pressures (no pulmonary artery hypertension). Among 29 patients with pulmonary arterial hypertension, 13 patients (22%) were having mild pulmonary arterial hypertension, 4 (8%) were with moderate pulmonary arterial hypertension, and 12 (24%) were with severe pulmonary arterial hypertension. Mean Qp/Qs was 2.73 ± 0.72 (2.5–4.5) and mean pulmonary vascular resistance was 1.5 ± 1.04 (0.6–4.6 WU). Amplatzer Duct Occluder (ADOI) was used in 15 (30%) cases, 27 (52%) cases were closed with Amplatzer Duct Occluder (ADOII), and the 3 (6%) cases closure was done with Amplatzer muscular ventricular septal defect occluder.Conclusions: Transcatheter closure of ventricular septal defect in children 10 kg or less is feasible and safe alternative to surgical ventricular septal defect closure. The immediate and short-term outcomes have proven this method to be safe and valid.

26 December 2024 in Cardiology in the Young
Verified
Journal Article
Open access
PDF file
SAShaad Abqari
Shaad Abqari
MKMohammad Moaaz Kidwai
Mohammad Moaaz Kidwai
MKMirza Mohd Kamran
Mirza Mohd Kamran
MHMohammad Azam Haseen
Mohammad Azam Haseen
SRShamayal Rabbani
Shamayal Rabbani
Introduction: Right ventricular outflow tract stenting has emerged as a key palliative intervention for infants with tetralogy of Fallot who are not suitable candidates for complete repair. Although the Blalock-Taussig shunt remains the standard palliative approach for tetralogy of Fallot patients over one year of age, the potential of right ventricular outflow tract stenting in this older age group has not been widely explored. In this study, we present our experience with right ventricular outflow tract stenting in children beyond one year of age.Methods and Results: In this study, a total of 52 patients of tetralogy of Fallot who underwent palliative stenting of the right ventricular outflow tract from 2018 to 2022 were enrolled. Out of the 52 patients, 38 children were more than 1 year of age with a mean age of 4.82 ± 3.5 (1.5–13 years) and mean weight of 13.10 ± 7.0 (5.6–34) kgs. Most common indication was presence of unfavourable anatomy in 27 (71%) followed by presence of refractory spells in 14 (36.8%) patients. Stent embolisation was seen in one patient, while two patients developed features of pulmonary oedema and needed prolonged ventilatory support. There was no mortality seen in this study group.Conclusion: Our study has shown that right ventricular outflow tract stenting in children even beyond one year of age is technically feasible, with good immediate outcomes, especially in those who present with any complication, thus reducing the perioperative morbidity and mortality.

6 March 2025
Verified
Book Chapter
Open access
PDF file
MKMirza Mohd Kamran
Mirza Mohd Kamran
RVOT stenting has traditionally been employed as a primary treatment for unrepaired tetralogy of Fallot (TOF) or other congenital heart defects characterized by VSD + Pulmonary stenosis physiology, particularly in neonates and young children experiencing significant cyanosis or symptoms of reduced Qp, serving as a temporary solution until complete surgical repair can be performed. Cyanotic congenital heart defects remain significant causes of morbidity and mortality, especially among infants and neonates. RVOT stenting additionally enhances the overall clinical condition of patients, thereby reinforcing its role as a viable and safe alternative to established palliative treatments aimed at addressing diminished Qp, such as Blalock–Taussig–Thomas shunts (BTT shunts) or central shunts. Nevertheless, in older patients (adolescents and adults), RVOT stenting presents a potential benefit as a definitive palliative solution. Its traditional function as a temporary procedure for newborns and infants with tetralogy of Fallot (TOF) who have anatomical challenges for complete repair. RVOT stenting improves the clinical condition of patients by increasing oxygen saturation and enhancing cardiac output, making it a potentially effective and safe option. RVOT stenting is believed to be more effective than traditional surgical palliation methods for older children and adult patients with unrepaired cyanotic congenital heart defects characterized by VSD + PS physiology, thereby effectively meeting the treatment objectives including improvement in oxygen saturation and promoting branch pulmonary artery growth.

28 February 2025 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
MKMirza Mohd Kamran
Mirza Mohd Kamran
AGArun Gopi
Arun Gopi
SDSaurabhi Das
Saurabhi Das
ZLZeeshan Lakhani
Zeeshan Lakhani
ASAmira Sheikh
Amira Sheikh
MMMusthafa P.P. Mohammad
Musthafa P.P. Mohammad
Background: When anomalous left coronary artery from the pulmonary artery is diagnosed in infancy, it is associated with high mortality, but collaterals permit rare adult survival despite coronary steal. We report normalisation of perfusion abnormality after transcatheter proximal left coronary occlusion in a symptomatic adult with inducible ischaemia. Methods: A forty-eight-year-old female presented with exertional chest pain; EKG showed sinus rhythm with left axis deviation with intraventricular conduction defect. Echocardiogram diagnosed an anomalous left coronary artery arising from the pulmonary artery with normal ventricular function which was further confirmed by CT. The case was discussed with the surgical team, and it was decided to surgically ligate. The patient did not give consent for the surgical procedure; the patient was taken up for the procedure. Results: Device was released safely after confirming the position on echocardiogram after the procedure showed improvement in intraventricular conduction defect and QTc duration, and also no significant ischaemic changes were noted. Myocardial perfusion scintigraphy was done after 6 months of procedure which showed improvement in contractile function and perfusion of left ventricle. Conclusions: Device closure in long-standing anomalous left coronary artery from pulmonary artery case is safe, and long-term follow-up is needed.

22 January 2026 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
SDSaurabhi Das
Saurabhi Das
SJShantanu Jain
Shantanu Jain
MKMirza Mohd Kamran
Mirza Mohd Kamran
SPSukanya Pathak
Sukanya Pathak
KSKangkan Sharma
Kangkan Sharma
NSNarendra Sharma
Narendra Sharma
Background: Percutaneous device closure is the preferred method for closing patent ductus arteriosus (PDA), even in preterm infants. We report our experience using the new KONAR-MFO™ ventricular septal defect occluder for transcatheter closure of preterm patent ductus arteriosus as an alternative device in resource-limited centres. Methodology: Case 1: A preterm baby with Down’s syndrome and tracheobronchomalacia was born at 29 weeks, weighing 1.68 kg with multiple cardiac defects, including a 4 mm PDA and a 6 mm mid-muscular ventricular septal defect (VSD), stuck on a ventilator. Case 2: Another preterm baby born at 35 weeks, weighing 1.89 kg, with anorectal malformation and a right inguinal hernia. The echocardiogram revealed a 4 mm PDA with severe PAH. In both cases, the patent ductus arteriosus was occluded using a 6 mm × 4 mm Konar MFO device on day 14 (case 1) and day 20 (case 2). Results: The baby (case 1) was weaned off the ventilator and discharged on the 28th postnatal day at 2.09 kg. As for case 2, the baby was weaned off the ventilator within 2 days and discharged on day 30 at 2.23 kg. A follow-up echocardiogram of both cases confirmed a well-positioned device with no obstructions. At 18 months, in the follow-up, both babies were gaining weight and thriving. Conclusions: The KONAR MFO device is a safe and effective option for patent ductus arteriosus closure in preterm infants, even in resource-limited settings. Its versatility accommodates various duct sizes and morphologies, and its self-expandable design ensures easy deployment, addressing the anatomical challenges often seen in preterm infants.